SAVA Q1 2017 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,388

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.42

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$1M

Stock-Based Comp.

$827,000

Balance Sheet

Total Assets

$18M

Total Liabilities

$883,000

Stockholders' Equity

$17M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,388	-$3,595	+61.4%
Operating Income	-$3M	-$6M	+52.6%
Net Income	-$3M	-$6M	+52.7%